GlassScriptPhysician profile
Kenneth Kaan
NPI 1083787493
$26,331.40
in general payments reported to CMS, 2019-2025
18 companies · $373 in 2025
The $373 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $4,219 · 2021: $433 · 2022: $1,746 · 2023: $8,538 · 2024: $442 · 2025: $373.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,710 · Food and Beverage: $2,643.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,710.31 |
| Food and Beverage | $2,643.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spineart USA INC | $23,120.89 | 2019-2023 | Perla C, Perla Tl, Romeo 2 |
| Amgen INC. | $991.77 | 2019-2024 | Evenity, Prolia |
| Radius Health, INC. | $535.68 | 2019-2023 | Tymlos |
| Cerapedics INC. | $431.05 | 2019-2025 | I-Factor Peptide Enhanced Bone Graft |
| Medtronic, INC. | $252.99 | 2021-2022 | |
| Zimmer Biomet Holdings, INC. | $149.22 | 2024 | |
| Globus Medical, INC. | $134.24 | 2025 | Xlif |
| Nuvasive, INC. | $132.77 | 2019 | |
| Medical Device Business Services, INC. | $109.97 | 2019 | |
| Carlsmed, INC. | $97.10 | 2025 | Aprevo |
| Heron Therapeutics, INC. | $95.74 | 2021-2023 | Zynrelef |
| Stryker Corporation | $70.33 | 2020-2021 | |
| Abbott Laboratories | $55.21 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $40.14 | 2023 | Exparel |
| Medtronic USA, INC. | $39.08 | 2019-2020 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $30.31 | 2019 | |
| Depuy Synthes Sales INC. | $25.71 | 2024 | Confidence Spinal Cement System |
| Allergan, INC. | $19.20 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Kaan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.